Pages that link to "Q40682400"

The following pages link to Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients (Q40682400):

Displaying 48 items.

• Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment (Q24803618) (← links)
• Angiotensin receptor gene polymorphisms and 2-year change in hyperintense lesion volume in men. (Q33940391) (← links)
• PharmGKB summary: very important pharmacogene information for angiotensin-converting enzyme (Q34994915) (← links)
• Renin-Angiotensin-Aldosterone Genotype Influences Ventricular Remodeling in Infants With Single Ventricle (Q35109802) (← links)
• Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System (Q35230775) (← links)
• Pharmacogenetics of antihypertensive drug response (Q35670639) (← links)
• Genes for left ventricular hypertrophy (Q35670654) (← links)
• Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy (Q35752881) (← links)
• Drug-gene interactions between genetic polymorphisms and antihypertensive therapy (Q35859028) (← links)
• A case for pharmacogenomics in management of cardiac arrhythmias. (Q35914690) (← links)
• Polymorphism in angiotensin II receptor genes and hypertension (Q36003958) (← links)
• Gene markers and antihypertensive therapy (Q36025918) (← links)
• Genomic variation and neurohormonal intervention in heart failure (Q36170188) (← links)
• Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets (Q36316001) (← links)
• Pharmacogenetics of antihypertensive treatment (Q36342985) (← links)
• Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker (Q36489410) (← links)
• Genetics of arterial hypertension and hypotension (Q36722035) (← links)
• Renin-angiotensin system revisited (Q37269647) (← links)
• Pharmacogenetics of cardiovascular drug therapy (Q37430401) (← links)
• Genetic polymorphisms related to the renin-angiotensin-aldosterone system and response to antihypertensive drugs. (Q37681549) (← links)
• Pharmacogenomic approaches to study the effects of antihypertensive drugs (Q38022144) (← links)
• Gene-environment interactions of selected pharmacogenes in arterial hypertension (Q38066959) (← links)
• Pharmacogenomics of heart failure: a systematic review (Q38998634) (← links)
• The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety (Q39456476) (← links)
• Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome. (Q40133099) (← links)
• Individual renal hemodymamic response to chronic angiotensin II receptor bloc­kade and the influence on the renin-angiotensin system gene polymorphisms (Q42744466) (← links)
• Interactive effect of angiotensin II type 1 receptor (AGT1R) polymorphisms and plasma irbesartan concentration on antihypertensive therapeutic responses to irbesartan (Q43600078) (← links)
• Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial (Q44001345) (← links)
• Variants of the CYP11B2 gene predict response to therapy with candesartan (Q44028382) (← links)
• Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). (Q44930351) (← links)
• Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension (Q44966749) (← links)
• Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients (Q45125171) (← links)
• Renin-angiotensin system and alpha-adducin gene polymorphisms and their relation to responses to antihypertensive drugs: results from the GENRES study (Q46213467) (← links)
• Effects of AGTR1 A1166C gene polymorphism in patients with heart failure treated with candesartan (Q46507308) (← links)
• The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Aten (Q46606291) (← links)
• Conceptual basis and methodology of the SOPHIA study (Q46885454) (← links)
• Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005. (Q48561405) (← links)
• Renoprotective efficacy of valsartan in chronic non‐diabetic proteinuric nephropathies with renin–angiotensin system gene polymorphisms (Q51158549) (← links)
• Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study. (Q55070146) (← links)
• Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or β-blockers (Q57781886) (← links)
• The Effect of Genetically Guided Mathematical Prediction and the Blood Pressure Response to Pharmacotherapy in Hypertension Patients (Q64067566) (← links)
• Relationship between a Weighted Multi-Gene Algorithm and Blood Pressure Control in Hypertension (Q64089122) (← links)
• Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women (Q80251093) (← links)
• The geographic distribution of the ACE II genotype: a novel finding (Q80522494) (← links)
• ACE genotype, risk and causal relationship to stroke: implications for treatment (Q80547471) (← links)
• The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure (Q83840973) (← links)
• Tagging SNPs in REN, AGTR1 and AGTR2 genes and response of renin activity, angiotensin II and aldosterone concentrations to antihypertensive treatment in Kazakans (Q84655492) (← links)
• Pharmacogenomics And Hypertension: Current Insights (Q91829792) (← links)